Edmond Teng1, Kanida Tassniyom, Po H Lu. 1. Neurobehavior Unit and Geriatric Research Education and Clinical Center, Veterans Affairs Greater Los Angeles Healthcare System, CA, USA. eteng@ucla.edu
Abstract
OBJECTIVES: To determine whether quality-of-life (QOL) ratings are reduced in mild cognitive impairment (MCI) and analyze correlations between QOL ratings and cognitive, neuropsychiatric, and functional indices in MCI. DESIGN: Cross-sectional. SETTING: The Easton Center for Alzheimer's Disease Research at the University of California, Los Angeles. PARTICIPANTS: A total of 205 individuals who met criteria for normal cognition (n = 97) or MCI (n = 108). The MCI group included amnestic (n = 72) and nonamnestic (n = 36) MCI. MEASUREMENTS: QOL was assessed using subject and informant ratings on the Quality of Life-Alzheimer's Disease (QOL-AD) scale. Cognitive performance was assessed with the National Alzheimer's Disease Coordinating Center Uniform Data Set neuropsychological battery. Neuropsychiatric symptoms were assessed with the Geriatric Depression Scale (GDS) and the Neuropsychiatric Inventory. Functional abilities were assessed with the Functional Activities Questionnaire (FAQ). RESULTS: The normal cognition group had significantly higher QOL-AD scores than the MCI group on both subject and informant assessments. Individual item analyses indicated that the largest group differences were seen on the mood and memory items. Similar QOL-AD scores were seen in the amnestic and nonamnestic MCI subgroups. Multiple regression analyses within the MCI group indicated that QOL-AD ratings were not correlated with neuropsychological performance. Subject QOL-AD ratings were inversely correlated with GDS scores and informant QOL-AD ratings were inversely correlated with GDS, Neuropsychiatric Inventory, and FAQ scores. CONCLUSIONS: Significant declines in QOL are seen in MCI and are associated with neuropsychiatric symptoms and functional decline. Interventions targeting mood symptoms and/or instrumental activities of daily living may improve QOL in MCI.
OBJECTIVES: To determine whether quality-of-life (QOL) ratings are reduced in mild cognitive impairment (MCI) and analyze correlations between QOL ratings and cognitive, neuropsychiatric, and functional indices in MCI. DESIGN: Cross-sectional. SETTING: The Easton Center for Alzheimer's Disease Research at the University of California, Los Angeles. PARTICIPANTS: A total of 205 individuals who met criteria for normal cognition (n = 97) or MCI (n = 108). The MCI group included amnestic (n = 72) and nonamnestic (n = 36) MCI. MEASUREMENTS: QOL was assessed using subject and informant ratings on the Quality of Life-Alzheimer's Disease (QOL-AD) scale. Cognitive performance was assessed with the National Alzheimer's Disease Coordinating Center Uniform Data Set neuropsychological battery. Neuropsychiatric symptoms were assessed with the Geriatric Depression Scale (GDS) and the Neuropsychiatric Inventory. Functional abilities were assessed with the Functional Activities Questionnaire (FAQ). RESULTS: The normal cognition group had significantly higher QOL-AD scores than the MCI group on both subject and informant assessments. Individual item analyses indicated that the largest group differences were seen on the mood and memory items. Similar QOL-AD scores were seen in the amnestic and nonamnestic MCI subgroups. Multiple regression analyses within the MCI group indicated that QOL-AD ratings were not correlated with neuropsychological performance. Subject QOL-AD ratings were inversely correlated with GDS scores and informant QOL-AD ratings were inversely correlated with GDS, Neuropsychiatric Inventory, and FAQ scores. CONCLUSIONS: Significant declines in QOL are seen in MCI and are associated with neuropsychiatric symptoms and functional decline. Interventions targeting mood symptoms and/or instrumental activities of daily living may improve QOL in MCI.
Authors: Gary Naglie; David B Hogan; Murray Krahn; B Lynn Beattie; Sandra E Black; Chris Macknight; Morris Freedman; Christopher Patterson; Michael Borrie; Howard Bergman; Anna Byszewski; David Streiner; Jane Irvine; Paul Ritvo; Janna Comrie; Matthew Kowgier; George Tomlinson Journal: Am J Geriatr Psychiatry Date: 2011-10 Impact factor: 4.105
Authors: Gary Naglie; David B Hogan; Murray Krahn; Sandra E Black; B Lynn Beattie; Christopher Patterson; Chris Macknight; Morris Freedman; Michael Borrie; Anna Byszewski; Howard Bergman; David Streiner; Jane Irvine; Paul Ritvo; Janna Comrie; Matthew Kowgier; George Tomlinson Journal: Am J Geriatr Psychiatry Date: 2011-10 Impact factor: 4.105
Authors: Maria I Lapid; Teresa A Rummans; Bradley F Boeve; Joan K McCormick; V Shane Pankratz; Ruth H Cha; Glenn E Smith; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen Journal: Int Psychogeriatr Date: 2011-02-01 Impact factor: 3.878
Authors: Kristiina Karttunen; Pertti Karppi; Asta Hiltunen; Matti Vanhanen; Tarja Välimäki; Janne Martikainen; Hannu Valtonen; Juhani Sivenius; Hilkka Soininen; Sirpa Hartikainen; Jaana Suhonen; Tuula Pirttilä Journal: Int J Geriatr Psychiatry Date: 2010-10-29 Impact factor: 3.485
Authors: Oscar Rosas-Carrasco; Laura del Pilar Torres-Arreola; M de Guadalupe Guerra-Silla; Sara Torres-Castro; Luis Miguel Gutierrez-Robledo Journal: Rev Neurol Date: 2010-07-16 Impact factor: 0.870
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Claire T McEvoy; Tina Hoang; Stephen Sidney; Lyn M Steffen; David R Jacobs; James M Shikany; John T Wilkins; Kristine Yaffe Journal: Neurology Date: 2019-03-06 Impact factor: 9.910
Authors: Sophie Laforest; Agathe Lorthios-Guilledroit; Kareen Nour; Manon Parisien; Michel Fournier; Dave Ellemberg; Danielle Guay; Charles-Émile Desgagnés-Cyr; Nathalie Bier Journal: Health Educ Res Date: 2017-04-01
Authors: Laura E Middleton; Maria I Ventura; Wendy Santos-Modesitt; Gina Poelke; Kristine Yaffe; Deborah E Barnes Journal: Contemp Clin Trials Date: 2017-10-21 Impact factor: 2.226